1. Wardlaw JM, Smith EE, Biessels GJ, Cordonnier C, Fazekas F, Frayne R, et al. Neuroimaging standards for research into small vessel disease and its contribution to ageing and neurodegeneration.
Lancet Neurol 2013;12:822-838.
2. Jessen NA, Munk AS, Lundgaard I, Nedergaard M. The glymphatic system: a beginner’s guide.
Neurochem Res 2015;40:2583-2599.
3. Rasmussen MK, Mestre H, Nedergaard M. The glymphatic pathway in neurological disorders.
Lancet Neurol 2018;17:1016-1024.
4. Wardlaw JM, Benveniste H, Nedergaard M, Zlokovic BV, Mestre H, Lee H, et al. Perivascular spaces in the brain: anatomy, physiology and pathology.
Nat Rev Neurol 2020;16:137-153.
5. Yao M, Zhu YC, Soumaré A, Dufouil C, Mazoyer B, Tzourio C, et al. Hippocampal perivascular spaces are related to aging and blood pressure but not to cognition.
Neurobiol Aging 2014;35:2118-2125.
6. Na HK, Kim HK, Lee HS, Park M, Lee JH, Ryu YH, et al. Role of enlarged perivascular space in the temporal lobe in cerebral amyloidosis.
Ann Neurol 2023;93:965-978.
7. Mortensen KN, Sanggaard S, Mestre H, Lee H, Kostrikov S, Xavier ALR, et al. Impaired glymphatic transport in spontaneously hypertensive rats.
J Neurosci 2019;39:6365-6377.
8. Maggi P, Macri SM, Gaitán MI, Leibovitch E, Wholer JE, Knight HL, et al. The formation of inflammatory demyelinated lesions in cerebral white matter.
Ann Neurol 2014;76:594-608.
9. Perosa V, Oltmer J, Munting LP, Freeze WM, Auger CA, Scherlek AA, et al. Perivascular space dilation is associated with vascular amyloid-β accumulation in the overlying cortex.
Acta Neuropathol 2022;143:331-348.
10. Doubal FN, MacLullich AM, Ferguson KJ, Dennis MS, Wardlaw JM. Enlarged perivascular spaces on MRI are a feature of cerebral small vessel disease.
Stroke 2010;41:450-454.
11. Yim Y, Moon WJ. An enlarged perivascular space: clinical relevance and the role of imaging in aging and neurologic disorders.
Taehan Yongsang Uihakhoe Chi 2022;83:538-558.
12. Alzheimer A, Stelzmann RA, Schnitzlein HN, Murtagh FR. An English translation of Alzheimer’s 1907 paper, “Uber eine eigenartige Erkankung der Hirnrinde”.
Clin Anat 1995;8:429-431.
13. Ramirez J, Berezuk C, McNeely AA, Scott CJ, Gao F, Black SE. Visible Virchow-Robin spaces on magnetic resonance imaging of Alzheimer’s disease patients and normal elderly from the Sunnybrook dementia study.
J Alzheimers Dis 2015;43:415-424.
14. Banerjee G, Kim HJ, Fox Z, Jäger HR, Wilson D, Charidimou A, et al. MRI-visible perivascular space location is associated with Alzheimer’s disease independently of amyloid burden.
Brain 2017;140:1107-1116.
15. Kim HJ, Cho H, Park M, Kim JW, Ahn SJ, Lyoo CH, et al. MRI-visible perivascular spaces in the centrum semiovale are associated with brain amyloid deposition in patients with Alzheimer disease-related cognitive impairment.
AJNR Am J Neuroradiol 2021;42:1231-1238.
16. Shams S, Martola J, Charidimou A, Larvie M, Granberg T, Shams M, et al. Topography and determinants of magnetic resonance imaging (MRI)-visible perivascular spaces in a large memory clinic cohort.
J Am Heart Assoc 2017;6:e006279.
17. Gertje EC, van Westen D, Panizo C, Mattsson-Carlgren N, Hansson O. Association of enlarged perivascular spaces and measures of small vessel and Alzheimer disease.
Neurology 2021;96:e193-e202.
18. Wang ML, Yu MM, Wei XE, Li WB, Li YH; Alzheimer’s Disease Neuroimaging Initiative. Association of enlarged perivascular spaces with Aβ and tau deposition in cognitively normal older population.
Neurobiol Aging 2021;100:32-38.
19. Vilor-Tejedor N, Ciampa I, Operto G, Falcón C, Suárez-Calvet M, Crous-Bou M, et al. Perivascular spaces are associated with tau pathophysiology and synaptic dysfunction in early Alzheimer’s continuum.
Alzheimers Res Ther 2021;13:135.
20. Passiak BS, Liu D, Kresge HA, Cambronero FE, Pechman KR, Osborn KE, et al. Perivascular spaces contribute to cognition beyond other small vessel disease markers.
Neurology 2019;92:e1309-e1321.
21. Paradise M, Crawford JD, Lam BCP, Wen W, Kochan NA, Makkar S, et al. Association of dilated perivascular spaces with cognitive decline and incident dementia.
Neurology 2021;96:e1501-e1511.
22. Hilal S, Tan CS, Adams HHH, Habes M, Mok V, Venketasubramanian N, et al. Enlarged perivascular spaces and cognition: a meta-analysis of 5 population-based studies.
Neurology 2018;91:e832-e842.
23. Choe YM, Baek H, Choi HJ, Byun MS, Yi D, Sohn BK, et al. Association between enlarged perivascular spaces and cognition in a memory clinic population.
Neurology 2022;99:e1414-e1421.
24. McKhann GM, Knopman DS, Chertkow H, Hyman BT, Jack CR Jr, Kawas CH, et al. The diagnosis of dementia due to Alzheimer’s disease: recommendations from the National Institute on Aging-Alzheimer’s Association workgroups on diagnostic guidelines for Alzheimer’s disease.
Alzheimers Dement 2011;7:263-269.
25. Albert MS, DeKosky ST, Dickson D, Dubois B, Feldman HH, Fox NC, et al. The diagnosis of mild cognitive impairment due to Alzheimer’s disease: recommendations from the National Institute on Aging-Alzheimer’s Association workgroups on diagnostic guidelines for Alzheimer’s disease.
Alzheimers Dement 2011;7:270-279.
26. Petersen RC, Smith GE, Waring SC, Ivnik RJ, Tangalos EG, Kokmen E. Mild cognitive impairment: clinical characterization and outcome.
Arch Neurol 1999;56:303-308.
27. Jessen F, Amariglio RE, van Boxtel M, Breteler M, Ceccaldi M, Chételat G, et al. A conceptual framework for research on subjective cognitive decline in preclinical Alzheimer’s disease.
Alzheimers Dement 2014;10:844-852.
28. Neary D, Snowden JS, Gustafson L, Passant U, Stuss D, Black S, et al. Frontotemporal lobar degeneration: a consensus on clinical diagnostic criteria.
Neurology 1998;51:1546-1554.
29. McKeith IG, Boeve BF, Dickson DW, Halliday G, Taylor JP, Weintraub D, et al. Diagnosis and management of dementia with Lewy bodies: fourth consensus report of the DLB consortium.
Neurology 2017;89:88-100.
30. Postuma RB, Berg D, Stern M, Poewe W, Olanow CW, Oertel W, et al. MDS clinical diagnostic criteria for Parkinson’s disease.
Mov Disord 2015;30:1591-1601.
31. Wenning GK, Stankovic I, Vignatelli L, Fanciulli A, CalandraBuonaura G, Seppi K, et al. The movement disorder society criteria for the diagnosis of multiple system atrophy.
Mov Disord 2022;37:1131-1148.
32. Höglinger GU, Respondek G, Stamelou M, Kurz C, Josephs KA, Lang AE, et al. Clinical diagnosis of progressive supranuclear palsy: the movement disorder society criteria.
Mov Disord 2017;32:853-864.
33. Armstrong MJ, Litvan I, Lang AE, Bak TH, Bhatia KP, Borroni B, et al. Criteria for the diagnosis of corticobasal degeneration.
Neurology 2013;80:496-503.
34. Wardlaw JM, Smith EE, Biessels GJ, Cordonnier C, Fazekas F, Frayne R, et al. Neuroimaging standards for research into small vessel disease and its contribution to ageing and neurodegeneration.
Lancet Neurol 2013;12:822-838.
35. Maclullich AM, Wardlaw JM, Ferguson KJ, Starr JM, Seckl JR, Deary IJ. Enlarged perivascular spaces are associated with cognitive function in healthy elderly men.
J Neurol Neurosurg Psychiatry 2004;75:1519-1523.
36. Martinez-Ramirez S, Pontes-Neto OM, Dumas AP, Auriel E, Halpin A, Quimby M, et al. Topography of dilated perivascular spaces in subjects from a memory clinic cohort.
Neurology 2013;80:1551-1556.
37. Benjamin P, Trippier S, Lawrence AJ, Lambert C, Zeestraten E, Williams OA, et al. Lacunar infarcts, but not perivascular spaces, are predictors of cognitive decline in cerebral small-vessel disease.
Stroke 2018;49:586-593.
38. Cordonnier C, Potter GM, Jackson CA, Doubal F, Keir S, Sudlow CL. Improving interrater agreement about brain microbleeds: development of the brain observer microbleed scale (BOMBS).
Stroke 2009;40:94-99.
39. Schmidt P, Gaser C, Arsic M, Buck D, Förschler A, Berthele A, et al. An automated tool for detection of FLAIR-hyperintense whitematter lesions in multiple sclerosis.
Neuroimage 2012;59:3774-3783.
40. Collij LE, Salvadó G, Shekari M, Lopes Alves I, Reimand J, Wink AM, et al. Visual assessment of [18F]flutemetamol PET images can detect early amyloid pathology and grade its extent.
Eur J Nucl Med Mol Imaging 2021;48:2169-2182.
41. Kang Y, Na DL. Seoul Neuropsychological Screening Battery. Incheon: Human Brain Research & Consulting, 2003.
42. Ryu HJ, Yang DW. The Seoul Neuropsychological Screening Battery (SNSB) for comprehensive neuropsychological assessment.
Dement Neurocogn Disord 2023;22:1-15.
43. Passiak BS, Liu D, Kresge HA, Cambronero FE, Pechman KR, Osborn K, et al. Perivascular spaces contribute to cognition beyond other small vessel disease markers.
Neurology 2019;92:e1309-e1321.
44. Jeong SH, Cha J, Park M, Jung JH, Ye BS, Sohn YH, et al. Association of enlarged perivascular spaces with amyloid burden and cognitive decline in Alzheimer disease continuum.
Neurology 2022;99:e1791-e1802.
45. Adams HH, Hilal S, Schwingenschuh P, Wittfeld K, van der Lee SJ, DeCarli C, et al. A priori collaboration in population imaging: the uniform neuro-imaging of Virchow-Robin spaces enlargement consortium.
Alzheimers Dement (Amst) 2015;1:513-520.
46. Kim KH, Seo JD, Kim ES, Kim HS, Jeon S, Pak K, et al. Comparison of amyloid in cerebrospinal fluid, brain imaging, and autopsy in a case of progressive supranuclear palsy.
Alzheimer Dis Assoc Disord 2020;34:275-277.